NovoTTF-100A FDA Approved

The FDA approved the NovoTTF-100A today. This is Novocure's head device that uses alternating electric fields that enter the brain through electrodes to kill cancer cells. Kent was one of the 237 patients in the pivotal clinical trial for this treatment. It didn't work for him but it has worked for a lot of other GBM IV patients, so this is great news in the brain tumor community.